SUN PHARMA ADVANCED RESEARCH COMPANY Financial Statement Analysis
|
||
The Revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have decreased by -68.36% YoY .
The Earnings Per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY has decreased by Negative YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Annual Financial Results
[BOM: 532872|NSE : SPARC]
Consolidated | Mar2024 | Mar2023 |
---|---|---|
Operating Income | ₹76 Cr | ₹239 Cr |
Operating Expenses | ₹140 Cr | ₹180 Cr |
Expenses | ₹478 Cr | ₹453 Cr |
Operating Profit (Excl OI) | ₹-402 Cr | ₹-214 Cr |
Other Income | ₹29 Cr | ₹11 Cr |
Interest | ₹1.70 Cr | ₹7.64 Cr |
Depreciation | ₹13 Cr | ₹12 Cr |
Profit Before Tax | ₹-387 Cr | ₹-223 Cr |
Profit After Tax | ₹-387 Cr | ₹-223 Cr |
Consolidated Net Profit | ₹-387 Cr | ₹-223 Cr |
Earnings Per Share (Rs) | ₹-11.93 | ₹-6.86 |
PAT Margin (%) | -512.56 | -93.22 |
ROE(%) | -121.28 | -43.41 |
ROCE(%) | -112.35 | -41.91 |
Total Debt/Equity(x) | 0.37 | 0.00 |
Key Financials |
||
Market Cap | : | ₹ 5,286.1 Cr |
Revenue (TTM) | : | ₹ 71.8 Cr |
Net Profit(TTM) | : | ₹ -342.5 Cr |
EPS (TTM) | : | ₹ -10.6 |
P/E (TTM) | : | - |
Industry Peers & Returns | 1W | 1M | 1Y |
SUN PHARMA ADVANCED RESEARCH COMPANY | -1.2% | 1.1% | -24.3% |
SYNGENE INTERNATIONAL | 0.3% | 2.3% | -7% |
SAGILITY INDIA | -1.7% | -14.6% | NA |
LATENT VIEW ANALYTICS | -2.9% | -5.3% | -21.3% |
JUST DIAL | -3.9% | -7.5% | -12.3% |
AWFIS SPACE SOLUTIONS | -1.9% | 8.7% | 40.9% |
MEDI ASSIST HEALTHCARE SERVICES | -1.9% | 6.3% | -9.1% |
JAYKAY ENTERPRISES | -5.1% | -9.4% | 120% |
ECOS (INDIA) MOBILITY & HOSPITALITY | -7.4% | 33.1% | NA |
SUN PHARMA ADVANCED RESEARCH COMPANY Revenues
[BOM: 532872|NSE : SPARC]
Y-o-Y | -68.36 % |
5 Yr CAGR | -68.36 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹76 Cr | -68.36 | |
Mar2023 | ₹239 Cr | - |
SUN PHARMA ADVANCED RESEARCH COMPANY Operating Profit
[BOM: 532872|NSE : SPARC]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹-402 Cr | Negative | |
Mar2023 | ₹-214 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | -532.26% | Negative | |
Mar2023 | -89.65% | - |
SUN PHARMA ADVANCED RESEARCH COMPANY Profit After Tax
[BOM: 532872|NSE : SPARC]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹-387 Cr | Negative | |
Mar2023 | ₹-223 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | -512.56 % | Negative | |
Mar2023 | -93.22 % | - |
SUN PHARMA ADVANCED RESEARCH COMPANY Earnings Per Share (EPS)
[BOM: 532872|NSE : SPARC]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹-12 | Negative | |
Mar2023 | ₹-6.86 | - |
SUN PHARMA ADVANCED RESEARCH COMPANY Return on Capital Employed (ROCE)
[BOM: 532872|NSE : SPARC]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | -112.35% | Negative | |
Mar2023 | -41.91% | - |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
Current Share Price | : | ₹162.9 |
Current MarketCap | : | ₹ 5,286.1 Cr |
Updated EOD on | : | Jun 16,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMA ADVANCED RESEARCH COMPANY | -1.2% |
1.1% |
-24.3% |
SENSEX | -0.8% |
-0.9% |
6.9% |
SUN PHARMA ADVANCED RESEARCH COMPANY related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
BSE HEALTHCARE | 1.6% | 3.8% | 20.8% |
BSE SMALLCAP | -0.9% | 6.2% | 8.8% |
BSE 500 | -1% | 1.1% | 5.2% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY MICROCAP 250 | -0.4% | 5.6% | 10.9% |
NIFTY TOTAL MARKET | -1% | 1.5% | 6.1% |
You may also like the below Video Courses
FAQ about SUN PHARMA ADVANCED RESEARCH COMPANY Financials
How the annual revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have changed ?
The Revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have decreased by -68.36% YoY .
How the Earnings per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY have changed?
The Earnings Per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY has decreased by Negative YoY .
SYNGENE INTERNATIONAL LTD vs SAGILITY INDIA LTD vs LATENT VIEW ANALYTICS LTD
JUST DIAL LTD vs AWFIS SPACE SOLUTIONS LTD vs